<code id='F2CD444147'></code><style id='F2CD444147'></style>
      • <acronym id='F2CD444147'></acronym>
      <center id='F2CD444147'><center id='F2CD444147'><tfoot id='F2CD444147'></tfoot></center><abbr id='F2CD444147'><dir id='F2CD444147'><tfoot id='F2CD444147'></tfoot><noframes id='F2CD444147'>
      • <optgroup id='F2CD444147'><strike id='F2CD444147'><sup id='F2CD444147'></sup></strike><code id='F2CD444147'></code></optgroup>
        5. <b id='F2CD444147'><label id='F2CD444147'><select id='F2CD444147'><dt id='F2CD444147'><span id='F2CD444147'></span></dt></select></label></b><u id='F2CD444147'></u>
          <i id='F2CD444147'><strike id='F2CD444147'><tt id='F2CD444147'><pre id='F2CD444147'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / explore      
           
     
           
      
          explore 
           
      
           
      
           
       2025-09-27 16:14:58 
   
      
           
      
           
                        
          explore  
          
                                   
                 
                                      author：hotspot   
                                        
                                      
                                      Page View：82
                                  
                                    
          
                                   
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. 																									Jim Mone/AP
          Home health and hospice chain Amedisys has chosen a new corporate owner.
          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.
          advertisement
          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          New oral drug delivery patch is modeled after octopus tentacles
                                
                            
          Next article：  
                                      
                                          Duchenne breakthrough therapy leaves behind pioneering families
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles